Milestone Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $-868 |
Gross Profit | -26 | -28 | ||
EBITDA | -11,418 | -9,616 | -8,515 | -9,522 |
EBIT | -11,444 | -9,641 | -8,541 | -9,550 |
Net Income | -12,363 | -9,439 | -9,363 | -10,354 |
Net Change In Cash | 0 | 0 | 0 | -868 |
Free Cash Flow | -6,865 | -7,022 | -6,060 | -8,934 |
Cash | 25,314 | 12,799 | 13,262 | 10,131 |
Basic Shares | 62,210 | 66,190 | 66,165 | 50,155 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $1,000 | $5,000 | $15,000 |
Gross Profit | 1,000 | 5,000 | 15,000 | |
EBITDA | -42,102 | -56,845 | -59,553 | -42,980 |
EBIT | -56,937 | -59,642 | -43,342 | |
Net Income | -41,519 | -59,685 | -57,134 | -42,633 |
Net Change In Cash | 0 | 1,000 | 5,000 | 15,000 |
Cost of Revenue | 41,831 | |||
Free Cash Flow | -28,848 | -46,536 | -52,741 | -33,224 |
Cash | 25,314 | 13,760 | 7,636 | 114,141 |
Basic Shares | 62,210 | 42,955 | 42,450 | 41,833 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.19 |
2024-09-30 | -$0.14 |
2024-06-30 | -$0.14 |
2024-03-31 | -$0.21 |
